Received: from mail-centralusazon11020111.outbound.protection.outlook.com (HELO DM1PR04CU001.outbound.protection.outlook.com) ([52.101.61.111]) by mx1.smit.ee with ESMTP/TLS/ECDHE-RSA-AES128-GCM-SHA256; 13 Apr 2026 11:13:45 +0300 Received: from mx1.smit.ee (10.151.55.67) by EX19-N5.meie.politsei.ee (10.153.17.18) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.2.2562.37 via Frontend Transport; Mon, 13 Apr 2026 11:13:47 +0300 Received: from SN7PR14MB4336.namprd14.prod.outlook.com ([fe80::6072:ebcc:2403:8195]) by SN7PR14MB4336.namprd14.prod.outlook.com ([fe80::6072:ebcc:2403:8195%5]) with mapi id 15.20.9769.046; Mon, 13 Apr 2026 08:13:40 +0000 Received: from SN7PR14MB4336.namprd14.prod.outlook.com (2603:10b6:806:108::9) by PH7PR14MB5715.namprd14.prod.outlook.com (2603:10b6:510:211::18) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.9769.48; Mon, 13 Apr 2026 08:13:40 +0000 Received: from EX19-N5.meie.politsei.ee (10.153.17.18) by EX19-N4.meie.politsei.ee (10.151.22.94) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.2.2562.37; Mon, 13 Apr 2026 11:13:47 +0300 Received: from EX19-N4.meie.politsei.ee (10.151.22.94) by EX19-N1.meie.politsei.ee (10.151.22.91) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.2.2562.37 via Mailbox Transport; Mon, 13 Apr 2026 11:13:48 +0300 From: "Olga Kruglova" To: "Politsei- ja Piirivalveamet" References: In-Reply-To: Subject: =?utf-8?Q?uued_ps=C3=BChhoaktiivsed_ained?= Date: Mon, 13 Apr 2026 11:13:40 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_0025_01DCCB56.C01B1AA0" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQHjaX3WTSUPOovE+gaAPitkWKQSOAIhnmMdALTnJBs= X-CSE-ConnectionGUID: c4U35sTSR4K4jzjc1jlUlg== X-CSE-MsgGUID: h8sUsaWDQHSLLK6vy8WOTQ== Authentication-Results: mx1.smit.ee; spf=Pass smtp.mailfrom=okruglova@caymaneurope.com; spf=Pass smtp.helo=postmaster@DM1PR04CU001.outbound.protection.outlook.com; dkim=pass (signature verified) header.i=@caymaneurope.com X-IPAS-Result: =?us-ascii?q?A0FYAwBl0LNpgW89ZTRXAx4BPAwCC4MiMVNBAUVgMgcIS?= =?us-ascii?q?YRYg0wDhSyKJZ5HKQ8BAQEBAQEBAQEHAkoHBAEBAwEDhQACFo0OIAYBSwECA?= =?us-ascii?q?QMBAQEBAwIDAQEBAQEBAQEBAQELAQEFAQEBAgEBAgQHAhABASIZBw47hk8BD?= =?us-ascii?q?IMWghYsCBciKgEfAgEDEhEKEwEBOA0CAgFHAwICAhgXFAYLAQEEEwgagmGCH?= =?us-ascii?q?QcESwQCDqN9AYE9AgKLIoEygQGCDAEBBgQEgQCBbdk1gWcJBYYkKIFqgWYBK?= =?us-ascii?q?oE1AQIOg3RIhEJCgUlEgVeHaxUKDBqDFDqCL4ESgRR6FB2BKIojBYFVhWeBR?= =?us-ascii?q?CIDJjMsAVUTFwsHBYFmAyovLW4yHYEjPhczWBsHBYUaD4lmbYERgygDC209N?= =?us-ascii?q?xQbAwSBNQWNE0MZPYNtAZlYi2CjdoQmog4XhASNE5lUhiKNB4VdIqh0AgQCB?= =?us-ascii?q?AUCEAEBBjaBSiKBXE0jgzcJRgMZD44tFoNebMgJRDQ8AgcBCgEBAwkBgjmED?= =?us-ascii?q?o0hAQE?= X-Talos-CUID: =?us-ascii?q?9a23=3AWrF44GtKsvBR/bbVfBN5GykG6IsuLkCGkWzsGHX?= =?us-ascii?q?kKjprWr+eEF2Uxadrxp8=3D?= X-Talos-MUID: =?us-ascii?q?9a23=3AiDzN6g+CvuLGfL3QI1+iVLeQf8c4+Jm1AX8hqLU?= =?us-ascii?q?9n+2nazJhawi6sA3iFw=3D=3D?= X-IronPort-Anti-Spam-Filtered: true X-IronPort-AV: E=Sophos;i="6.23,117,1770588000"; d="scan'208,217";a="18182658" X-SPF: Fail X-MS-Exchange-Organization-Network-Message-Id: 13c64457-37ce-4e17-a6dd-08de993496b4 X-MS-Exchange-Organization-AVStamp-Enterprise: 1.0 X-MS-Exchange-Organization-AuthSource: EX19-N5.meie.politsei.ee X-MS-Exchange-Organization-AuthAs: Anonymous X-MS-Exchange-Transport-EndToEndLatency: 00:00:00.2376469 X-MS-Exchange-Processed-By-BccFoldering: 15.02.2562.037 Content-Language: en-us x-ms-exchange-organization-originalclientipaddress: 10.151.55.67 x-ms-exchange-organization-originalserveripaddress: 10.153.17.18 received-spf: Pass (mx1.smit.ee: domain of postmaster@DM1PR04CU001.outbound.protection.outlook.com designates 52.101.61.111 as permitted sender) identity=helo; client-ip=52.101.61.111; receiver=mx1.smit.ee; envelope-from="okruglova@caymaneurope.com"; x-sender="postmaster@DM1PR04CU001.outbound.protection.outlook.com"; x-conformance=spf_only; x-record-type="v=spf1"; x-record-text="v=spf1 ip4:40.92.0.0/15 ip4:40.107.0.0/16 ip4:52.100.0.0/15 ip4:52.102.0.0/16 ip4:52.103.0.0/17 ip4:104.47.0.0/17 ip6:2a01:111:f400::/48 ip6:2a01:111:f403::/49 ip6:2a01:111:f403:8000::/51 ip6:2a01:111:f403:c000::/51 ip6:2a01:111:f403:f000::/52 -all" dkim-signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=caymaneurope.com; s=selector2; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=OlwQK5BP9Nl1kp21AlbDdXCLm+nGHVRYodVghebB8Lo=; b=C5nPDpTjkbO6skQkm9OzxaskWrvzySFK8Nto3nri3GxlUD0pTiHg1w1Ra8B2GDAwyU9FN3Nxe8vHSZ3+ats1A8C5JRM5RlNHnkMVpA+dhd2lKgSqVSqeZEiBeAN6ba0jYL7PnYvH0UgV+LaY18UneDHU/tF7+cE+o2yzxrifdfA= X-OlkEid: 00000000456ED7599191A247839F8DE5017ACD8B070034AD76187591974DBF6C4F76951C873A010008000000000028DD0165831C864EA63BBF4345EFF3D800000000186A0000B7B8EEE58911A944831A56DE8E841B25 X-MS-Has-Attach: X-MS-TNEF-Correlator: x-ms-publictraffictype: Email x-ms-traffictypediagnostic: SN7PR14MB4336:EE_|PH7PR14MB5715:EE_ x-ms-office365-filtering-correlation-id: 72cfd5fe-e9c1-4b55-468f-08de99349214 x-ms-exchange-senderadcheck: 1 x-ms-exchange-antispam-relay: 0 x-microsoft-antispam: BCL:0;ARA:13230040|376014|1800799024|366016|10070799003|38070700021|8096899003|13003099007|56012099003|22082099003|18002099003; x-microsoft-antispam-message-info: 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 x-forefront-antispam-report: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:SN7PR14MB4336.namprd14.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(376014)(1800799024)(366016)(10070799003)(38070700021)(8096899003)(13003099007)(56012099003)(22082099003)(18002099003);DIR:OUT;SFP:1102; x-ms-exchange-antispam-messagedata-chunkcount: 2 x-ms-exchange-antispam-messagedata-0: =?utf-8?B?YnZWb1dCajFaY2U3azNuT0d1WDlZWTJmTHE1ZFMxSGlvVHB0cHhTUWdUM0s3?= =?utf-8?B?REV5V2ZXZWxMLzJqUnRWY3dQKzdRL0hwVlhzNHhmYmozSUhqNCtWZW9qS09n?= =?utf-8?B?OEVEQzNhd0xCeEVPcHBDZGxRM2x0cTdhcjhIM2lMSmt4aThRRUp2anZmbk81?= =?utf-8?B?WEhjVXkvcGlLV2xwSFVWQ2NqZzRhampZbXZoYmNjRlc0eXNKMG1kUVVVNTFR?= =?utf-8?B?eVRSVXFRNTdNUWlzVldnZ3hPa1ZGMG5jR29WODA2VWN0Zk5xcDFEKzJOZmhI?= =?utf-8?B?V3NtZ2NDWCtLRlJMcUFPcGpLb2N0ZTBCZEs5cEYvWE8vK1JHeDdBUXpHTFJI?= =?utf-8?B?WnFNZnVMMGdlaU9FSDRaay9wc2hlTVlMSHc1dGJIejkzVEJnYUh5KzIvNTM1?= =?utf-8?B?bFlnRjR0Mnd6RFJpVXI0RUg5VzRncXNxODlJOC8wZWlpc2VBV2F5TnRoMUI1?= =?utf-8?B?UDlYSnJxdzhNNFNYU0FTQkdFYlFiamFWd3VPblBHQ2F6WnI1SElGUGNoWjVB?= =?utf-8?B?WENrZTJZTWtuNW9BV3BvbVR0SmxuNFRyRHlQQnQzYkZ1VDdlcFJDaWZGVXF1?= =?utf-8?B?cVA0aEZxS1pLMG9rSnRPbU55czlrOWcvN3NnSDYwVUZ2WG1WMjNhZ010eEhL?= =?utf-8?B?KzZ3YkhKMkJPUnVXU0FtdzRSelJiUklOTk42Nnl1WWF6ZnQxa2Jtd3o3VlNS?= =?utf-8?B?eDl4TlV5ZjdPR3M3LzJKTzhhMy8vdDY5dzZsVFVwVlpBelYwVmVYK0tRY04r?= =?utf-8?B?ekdSVnA1d0NMTlZ rdG92WlpjMHkySkVuWkJDRlA4c1o1WGNNTEpwMnBEdW4y?= =?utf-8?B?amZ3Q0pTdDcrbzgzTGR0RFpxNEpKemsxeXJKL2plY3ZiU0lmaEhFWjZXbUdJ?= =?utf-8?B?UFpLL013YzU4UU12Q2swWE1KeHZmWjhHVFlmU1pvQ0tYZ0RzTnlYUlBWMDRw?= =?utf-8?B?YTloZGpzellsRkszRzlpSm5udXZaaWE0TForRzl5OHFjVVI2Z0k4eTY1aFZH?= =?utf-8?B?MTk4eDloejlOVktZaktWd2JFa0xNL3d2ZkhQeldSamxxeEFWWEJIKzlOeHlR?= =?utf-8?B?dkYwdUtHTWtwT3dJSWZvMG03bEJ0SkJ1c2pYRFpObm9NcVFGVy91eFJWNVhJ?= =?utf-8?B?WDZyZVZHdXpyN3FRRkx1K0pveGdtU0xXczRvVFJiWDljRDhPdS8zc2syWHZQ?= =?utf-8?B?M1BWUGdtNmNVVExFVWIzeWYwN0crTWs5ZHU0YUxrdFM3eDBhRnVsU2FPQkpL?= =?utf-8?B?Y05GMjRxcm5pV2pBT0VWWVIwWFVtWjF6NGMwZnNpNGNreXRoVUtkRGtkenlN?= =?utf-8?B?Q3dDOTZKc0VmSGVxM2tmbFRTcnhKaE9aNWtyUHlsL1lnVGRiZ3FQVHRTNmdK?= =?utf-8?B?SWJiMG94bzk4ZFNxaWkvL2NObkNxbzJEQ3BJVmFubnE2Y0JoeVFaU09Qdm9R?= =?utf-8?B?aVpUWU4yeG8xZ1d0VjUrYytDM24xRUZEZDB6b1ZteWVraktXdDdyRnhSdFRY?= =?utf-8?B?Zzdoc1QvYXJnZnJCOVV6aStsZ0paZ29sbjV2L2JHZTJvZlc3elFUNXliRlBV?= =?utf-8?B?a2NVUUw0UVBCNjY2aVNIS2E1RC9QT1llNTlrQklB cmlqMHlOUTEyalV5WkJy?= =?utf-8?B?U3NmSDJXRXh2SURDKzdTUldzaURLZ2pmSlhrTUc5ZGlJcitXbFY1dHRJdFdk?= =?utf-8?B?eU81YjB2SUxNaTN1MEQyZWxqamlNbFZYR0l4b1NrQW1GcWNtOUl2L0pueHVv?= =?utf-8?B?QmhZK0xFcjRPMFpnaXRhNDhIMTVGVWxDdmgyakpKaTI0dVlIQ0Q4RzkxaTl1?= =?utf-8?B?Y3pIWGdHTGRCOS8wV1NUbmZBZ2hRQitBcUoyV3IrV2t5RlE2UkNyZkJ0TVVj?= =?utf-8?B?a1dQeTVRdk52TXFkVTR5NW9PMGRNanVQTkpYSmRpcGFKRGU3WWgyZHZ3cE5I?= =?utf-8?B?WnBraFY3dkMwR203bDRpa0NTMEFrM3BrSUtLMzFyMjRTTldlN2lBUzUxVnZk?= =?utf-8?B?bHJvY1FjS1JPVkNSZHVCeGJ0OG5VaFNXNUJnd1EzSDg1UjB4elVNek9XVXI0?= =?utf-8?B?aUtOVTlWcmVOZGdtdkVLSGd3SUovbVpxOTdJSnRkVnFrdlNaRHBTellKa1dK?= =?utf-8?B?WDRPSFVabGZOWWRoMHZ4dk9SZkhiK2E4NGlnUmgvdlFNR2dUb1F6MUUxSXNN?= =?utf-8?B?YWhFVERpNUxxY1dRTmI4bE5oRDk1L21GYlFpOVJobE41a2F1K3JQRWsyNURI?= =?utf-8?B?bXd4VFB1VGVPbDdKOWx3K3lwVC92Skt6NHJxWHpRdk5FTFZmK3NNa0FuSUJL?= =?utf-8?B?OVVwWUtvSUJOS0M5WnRNMXFhWlcyektnbkRFSER5UjMxNjNZaWU4NGs2WmJE?= =?utf-8?Q?q0jLFzjzJW8J2RPCIkWC0+NPPoa63WJLi4L6KyOmts6au?= X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-AuthSource: SN7PR14MB4336.namprd14.prod.outlook.com X-MS-Exchange-CrossTenant-Network-Message-Id: 72cfd5fe-e9c1-4b55-468f-08de99349214 X-MS-Exchange-CrossTenant-originalarrivaltime: 13 Apr 2026 08:13:40.1034 (UTC) X-MS-Exchange-CrossTenant-fromentityheader: Hosted X-MS-Exchange-CrossTenant-id: 199ba143-5699-42b8-ac89-8b3ec3060b1b X-MS-Exchange-CrossTenant-mailboxtype: HOSTED X-MS-Exchange-CrossTenant-userprincipalname: apV1s+Tv0wZEZHBLxMgy8YVIxQeWNHxao34ZBAlV5HMblAo+IcNyt30Sl0fpS5nZ/U2NN8rq0QcqgCqx1+qYdeFyNxtezz3xiCPCfUAqFBY= X-MS-Exchange-Transport-CrossTenantHeadersStamped: PH7PR14MB5715 msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-04-10T13:06:14.039Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; acceptlanguage: en-US X-Ironport-Dmarc-Check-Result: validskip x-ms-exchange-antispam-messagedata-1: jJhsdbie9OxuTQ== This is a multipart message in MIME format. ------=_NextPart_000_0025_01DCCB56.C01B1AA0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Lp. Politsei-ja Piirivalveamet! Kas oleks võimalik nõu küsida uute psühhoaktiivsete ainete osas? Politsei-ja Piirivalveameti webi info alusel on ainult lingil olevad ained kuuluvad uute psühhoaktiivsete ainete hulka https://www.politsei.ee/et/juhend/ennetusalased-materjalid/uued-ajutise-kaitlemispiiranguga-psuhhoaktiivsed-ained . Võrdlesin nimekirja eelmisega ja tundub, et mõned ained on kadunud sealt listist. Samas ei ole ained lisandunud NARKOOTILISTE JA PSÜHHOTROOPSETE AINETE JA AINERÜHMADE NIMEKIRJADESSE. Kas see tähendab, et ained ei ole enam reguleeritud ja ma saan neid mitte-reguleerituks märkida oma süsteemis: * (±)-threo-4-Methylmethylphenidate * 1cP-MiPLA * 3-hydroxy PCP * Delta 9-Tetrahydrocannabivarin * Delta 8-Tetrahydrocannabivarin Please let me know if I can help further. Best regards, Olga Kruglova Manager of Regulated Markets Development Cayman Europe OÜ Akadeemia tee 21/5 Tallinn 12618, Estonia Phone: +372 670 3232 Fax: +372 670 3683 okruglova@caymaneurope.com www.caymanchem.com ------=_NextPart_000_0025_01DCCB56.C01B1AA0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable

Lp.= Politsei-ja Piirivalveamet!

 

Kas= oleks v=C3=B5imalik n=C3=B5u k=C3=BCsida uute ps=C3=BChhoaktiivsete = ainete osas? Politsei-ja Piirivalveameti webi info alusel on ainult = lingil olevad ained kuuluvad uute ps=C3=BChhoaktiivsete ainete hulka https://www.politsei.ee/et/juhend/ennetusalased-m= aterjalid/uued-ajutise-kaitlemispiiranguga-psuhhoaktiivsed-ained . V=C3=B5rdlesin nimekirja eelmisega ja tundub, et m=C3=B5ned ained on = kadunud sealt listist. Samas ei ole ained lisandunud NARKOOTILISTE JA = PS=C3=9CHHOTROOPSETE AINETE JA AINER=C3=9CHMADE NIMEKIRJADESSE. Kas see = t=C3=A4hendab, et ained ei ole enam reguleeritud ja ma saan neid = mitte-reguleerituks m=C3=A4rkida oma s=C3=BCsteemis:

&nb= sp;

  • (=C2= =B1)-threo-4-Methylmethylphenidate
  • 1cP= -MiPLA
  • 3-h= ydroxy PCP
  • Del= ta 9-Tetrahydrocannabivarin
  • Del= ta 8-Tetrahydrocannabivarin

&nb= sp;

Ple= ase let me know if I can help further.

&nb= sp;

Bes= t regards,

Olg= a Kruglova

Man= ager of Regulated Markets Development

Cay= man Europe O=C3=9C

Aka= deemia tee 21/5

Tal= linn 12618, Estonia

Pho= ne: +372 670 3232

Fax= : +372 670 3683

okruglova@caymaneurope.com

www.caymanchem.com

&nb= sp;

------=_NextPart_000_0025_01DCCB56.C01B1AA0--